title: [Maternal hyperphenylalaninemia in a population of healty Czech women. 18 years' experience with mass screening, diet therapy and metabolic monitoring].
abstract: BACKGROUND
  Elevated phenylalanine levels in maternal blood (hyperphenylalaninaemia) during pregnancy damages the developing foetal tissues. Early detection of pregnant women with hyperphenylalaninaemia and adherence to a low phenylalanine diet already before conception and throughout pregnancy can prevent this damage. The objective of the investigation are results achieved screening and strict monitoring of low phenylalanine dietetic treatment in detected pregnant women of the Prague population.
  
  
  RESULTS
  186 350 healthy women of the Prague population were examined by the chromatographic screening test in a venous blood sample during their first visit in a maternity welfare centre and 22 positive cases were detected (incidence 1:8470). In 86% mild, persistent or benign forms of phenylketonuria were involved. Nineteen patients were treated by a low phenylalanine diet and the phenylalanine tolerance was monitored as well as the nitrogen balance, amino acids in serum and urine, protein markers, trace elements, vitamins, lipids, the body mass index-BMI, changes of body weight after introduction of the dietetic treatment and treatment during pregnancy. A significant increase of the phenylalanine tolerance by 20 to 200% was found, mostly in the second half of pregnancy and reduced values of serum and urinary selenium. The decrease of body weight when the diet was introduced and the increment during pregnancy correlated with the BMI value. In the other investigated parameters no significant deviations were found.
  
  
  CONCLUSIONS
  Fifteen healthy children with normal psychomotor development delivered by 12 mothers with hyperphenylalaninaemia provide evidence of the effectiveness of prenatal screening for hyperphenylalaninaemia during pregnancy.
authors.affiliation: Centrum dĕdicných metabolických poruch, II. gynekologicko-porodnická klinika, Praha.
authors.forename: J
authors.initials: J
authors.lastname: Hyánek
authors.forename: J
authors.initials: J
authors.lastname: Bendl
authors.forename: J
authors.initials: J
authors.lastname: Zeman
authors.forename: K
authors.initials: K
authors.lastname: Soukup
authors.forename: A
authors.initials: A
authors.lastname: Dolezal
authors.forename: V
authors.initials: V
authors.lastname: Kozich
authors.forename: S
authors.initials: S
authors.lastname: St'astná
authors.forename: M
authors.initials: M
authors.lastname: Kubík
authors.forename: H
authors.initials: H
authors.lastname: Viletová
mesh_terms: D000293:Adolescent; D000328:Adult; D018153:Czech Republic / Q000453:epidemiology; D005260:Female; D006801:Humans; D015994:Incidence; D007231:Infant, Newborn; D008403:Mass Screening; D010649:Phenylalanine / Q000097:blood*; D017042:Phenylketonuria, Maternal / Q000175:diagnosis / Q000178:diet therapy / Q000453:epidemiology*; D010661:Phenylketonurias / Q000517:prevention & control; D011247:Pregnancy; D011248:Pregnancy Complications / Q000175:diagnosis* / Q000178:diet therapy / Q000453:epidemiology
chemical_list: D010649:Phenylalanine